Cargando…
Prophylactic cranial irradiation in non-small cell lung cancer: evidence and future development
In non-small cell lung cancer (NSCLC) brain metastases (BM) will affect up to 50% of patients during whole disease period. BM themselves impact heavily not only on patient’s prognosis but also are a source of symptoms aggravating quality of life. Standard (pemetrexed), and non-standard chemotherapy...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182492/ https://www.ncbi.nlm.nih.gov/pubmed/34164220 http://dx.doi.org/10.21037/jtd.2019.11.36 |